UC San Diego will be one of several sites across the country to study the safety and efficacy of the drug tecovirimat as a potential treatment for human monkeypox, it was announced Thursday.
UC San Diego will be one of several sites across the country to study the safety and efficacy of the drug tecovirimat as a potential treatment for human monkeypox, it was announced Thursday.
This website, like most media sites, uses small files called cookies to anonymously customize the advertising that you see. Learn more about how we use cookies in our cookie policy.